Viewing nowBontil Tablet 35mg (Risedronate Sodium 2.5 Hydrate)
Risedronate Sodium 2.5 Hydrate 40.17mg
Tablet · Prescription medication
Shinpoong Pharmaceutical Co., Ltd.

MFDS item code 200713914 · Notified 2007.12.31 · Insurance code 648504750
Treatment and prevention of osteoporosis in postmenopausal women; treatment of osteoporosis in men
This medication is used for the treatment and prevention of osteoporosis in postmenopausal women and men.
<5mg> Adults: Administer one 5mg tablet orally once daily. No dosage adjustment is necessary in elderly patients (60 years and older), because the bioavailability and pharmacokinetics of this drug are similar to those in younger people. No dosage adjustment is necessary in patients with a creatinine clearance of 30ml/min or higher. This drug is contraindicated in patients with severe renal impairment and a creatinine clearance of less than 30ml/min. Take at least 30 minutes before breakfast, or at any time of day at least 2 hours before or after consuming food or beverages. Take in an upright position with a sufficient amount of plain water (170 ~ 230ml). Taking this drug with other beverages, including mineral water, may reduce its absorption. Do not chew or suck this drug because of the possibility of oropharyngeal ulceration. Patients should not lie down for at least 30 minutes after taking this drug. <35mg> Adults: Administer one 35mg tablet orally once weekly. No dosage adjustment is necessary in elderly patients (60 years and older), because the bioavailability and pharmacokinetics of this drug are similar to those in younger people. No dosage adjustment is necessary in patients with a creatinine clearance of 30ml/min or higher. This drug is contraindicated in patients with severe renal impairment and a creatinine clearance of less than 30ml/min. Take at least 30 minutes before breakfast, or at any time of day at least 2 hours before or after consuming food or beverages. Take in an upright position with a sufficient amount of plain water (170 ~ 230ml). Taking this drug with other beverages, including mineral water, may reduce its absorption. Do not chew or suck this drug because of the possibility of oropharyngeal ulceration. Patients should not lie down for at least 30 minutes after taking this drug. If a patient forgets to take a dose on the scheduled day, take it the next morning when remembered. Take the next dose on the regularly scheduled day. Do not take 2 tablets on the same day. <150mg> Adults: Take 1 tablet of this drug orally once a month. No dosage adjustment is necessary in elderly patients (60 years and older), because the bioavailability and pharmacokinetics of this drug are similar to those in younger people. No dosage adjustment is necessary in patients with a creatinine clearance of 30ml/min or higher. This drug is contraindicated in patients with severe renal impairment and a creatinine clearance of less than 30ml/min. Take at least 30 minutes before consuming food or any beverage other than water. Take in an upright position with a sufficient amount of plain water (170 ~ 230ml). Taking this drug with other beverages, including mineral water, may reduce its absorption. Do not chew or suck this drug because of the possibility of oropharyngeal ulceration. Patients should not lie down for at least 30 minutes after taking this drug. If a patient forgets to take a dose on the scheduled day, take it as follows. - If the next scheduled dose is 7 days or more away, take 1 tablet of this drug the next morning when remembered. Take the next dose on the regularly scheduled day. Do not take more than 1 tablet of this drug within 7 days. - If the next scheduled dose is within 7 days, wait until the regularly scheduled dose day and then take 1 tablet of this drug.
Safety and efficacy in children and adolescents during growth have not been established.
This medication may irritate the upper gastrointestinal tract, so caution is especially needed for those with issues in the esophagus or stomach. Take with a sufficient amount of water, and do not lie down for a period of time after taking the medication to prevent esophageal damage. If symptoms such as pain in the esophagus or difficulty swallowing occur, stop taking the medication immediately and consult a doctor. Those with delayed esophageal clearance, allergies to any of this medication's ingredients, hypocalcemia, pregnant or nursing women, and those with severe renal impairment should not take this medication. If calcium and vitamin D deficiency exists, treatment should be ensured before taking this medication, and it is recommended to take calcium and vitamin D supplements concurrently. Bisphosphonate class medications can rarely cause serious side effects such as osteonecrosis of the jaw or atypical femur fractures, so caution is needed with long-term use. When taking this medication, avoid taking it with foods or medications containing calcium, magnesium, or iron, as this can interfere with absorption and effectiveness. Pregnant women or those who may become pregnant should not take this medication, and nursing mothers should either stop taking it or cease breastfeeding. It is advisable not to use this medication in children, as safety and efficacy have not been established. In case of overdose, symptoms of hypocalcemia may appear, and immediate medical assistance should be sought. This medication should be stored out of the reach of children, and transferring it to another container should be avoided.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent exposure to air and moisture, ideally at room temperature between 1°C and 30°C. Proper storage will maintain the medication's efficacy and prevent degradation.
Pale orange, rectangular, film-coated tablet
4 tablets (4 tablets/PTP X 1)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowRisedronate Sodium 2.5 Hydrate 40.17mg
Tablet · Prescription medication
Shinpoong Pharmaceutical Co., Ltd.

Risedronate Sodium 2.5 Hydrate 40.17mg
Tablet · Prescription medication
Austin Pharmaceutical Co., Ltd.

Risedronate Sodium 2.5 Hydrate 40.17mg
Tablet · Prescription medication
Nexpam Korea Co., Ltd.

Risedronate Sodium 2.5 Hydrate 35mg
Tablet · Prescription medication
Hyutecs Pharmaceutical Co., Ltd.

Risedronate Sodium 2.5 Hydrate 40.2mg
Tablet · Prescription medication
Celix Co., Ltd.

Risedronate Sodium 2.5 Hydrate 40.17mg
Tablet · Prescription medication
Myeongmun Pharmaceutical Co., Ltd.

Risedronate Sodium 2.5 Hydrate 40.17mg
Tablet · Prescription medication
Korea United Pharmaceutical Co., Ltd.

Risedronate Sodium 2.5 Hydrate 40.17mg
Tablet · Prescription medication
Dongkwang Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.